AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...

TAINAN, Jan. 5, 2026 /PRNewswire/ -- ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) ...

If an optional autoinjector is used for administration, patients should ensure the device is compatible for use with their specific glatiramer acetate product. The labels for glatiramer acetate ...

Glatiramer acetate injection is a treatment for multiple sclerosis. ScinoPharm Taiwan pointed out that since its approval in 1996, glatiramer acetate has been recognized as one of the most challenging ...

Senior patient talks about autoinjector with her doctor. Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis. The Food and Drug Administration (FDA) ...

--Glatopa 40 mg/mL is a fully substitutable, AP-rated generic version of three times-a-week COPAXONE ® (glatiramer acetate injection) 40 mg/mL for the treatment of patients with relapsing forms of ...

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced today that it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its ...

NESS ZIONA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting ...